Robert J. Weiland Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert J. Weiland.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert J. Weiland. Robert J. Weiland is Director in CymaBay Therapeutics, Inc. ($CBAY) and Chief Commercial Officer in Pacira Pharmaceuticals, Inc. ($PCRX).
Latest Insider Trading Transactions of Robert J. Weiland
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 31 2019 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 8.43 | 27,705 | 233,553 | 27,705 | |
Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Sell | S | 33.02 | 373 | 12,316 | 5,088 | 5.5 K to 5.1 K (-6.83 %) |
Jan 26 2018 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 11.69 | 16,000 | 187,040 | 16,000 | |
Sep 26 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 7.47 | 7,500 | 56,025 | 7,500 | |
Jun 30 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 5.50 | 15,000 | 82,500 | 15,000 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 44.20 | 9,000 | 397,800 | 9,000 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Grant | A | 0.00 | 4,500 | 0 | 4,864 | 364 to 4.9 K (+1,236.26 %) |
Jan 23 2017 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 1.72 | 12,000 | 20,640 | 12,000 | |
Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 32.35 | 16,000 | 517,600 | 16,000 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 40.34 | 10,000 | 403,400 | 10,000 | |
May 04 2016 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 51.54 | 40,000 | 2,061,600 | 40,000 | |
Apr 28 2016 | CBAY | CymaBay Therapeuti ... | Weiland Robert J. | Director | Option Exercise | A | 2.81 | 18,000 | 50,580 | 18,000 |
Page: 1